Sean McClain
Portland, Oregon,United States
Find Sean McClain's Email
Find Sean McClain’s PhoneSean McClain's Overview
Sean McClain is a visionary scientist and entrepreneur, best known as the founder and CEO of Absci (NASDAQ: ABSI). He established the company in 2011 with the mission to revolutionize drug discovery by unifying artificial intelligence with scalable wet-lab technologies. McClain leads Absci's efforts in developing its integrated drug creation platform, which aims to design novel biologics and accelerate the path to clinical trials, ultimately getting better medicines to patients faster. His work sits at the intersection of synthetic biology, machine learning, and protein engineering, positioning Absci as a pioneer in the field of generative AI drug creation.
Professional Summary
Sean McClain's work history includes a series of influential roles in various companies. Here is a detailed list of his professional journey:
Notable Achievements
Founder & CEO of Absci
Founded Absci in 2011 in a basement laboratory, pioneering the concept of generative AI drug creation and growing it into a publicly traded leader in the biotechnology space.
Led Absci to a Successful IPO
Successfully guided Absci through its Initial Public Offering on the Nasdaq in July 2021, raising significant capital to scale the company's platform and research capabilities.
Ernst & Young Entrepreneur Of The Year® 2020
Recognized as the EY Entrepreneur Of The Year for the Pacific Northwest Region, an award celebrating his leadership, innovation, and impact on the biotechnology industry.
Forged Major Pharmaceutical Partnerships
Spearheaded and secured strategic, multi-year collaborations with top-tier pharmaceutical companies, including Merck and AstraZeneca, to discover and develop next-generation antibody-based therapies.
Educational Background
Biochemistry and Molecular Biology
University of Arizona
Buying Intent Signals for Sean McClain
Highperformr Signals uncover buying intent and give you clear insights to target the right people at the right time — helping your sales, marketing, and GTM teams close more deals, faster.
Company Overview
AbsciAbsci is a drug creation company that leverages its Integrated Drug Creation™ platform, which combines generative AI with scalable wet-lab technologies, to design and validate novel biologics for pharmaceutical partners. The company's approach aims to accelerate the discovery of optimal drug candidates, potentially reducing the time and cost associated with bringing new medicines to patients.
Highperformr's free tools for company research
Find contact info
Get verified emails, phone numbers, and LinkedIn profile details
Find similar contacts
Discover contacts with similar roles, seniority, or companies
Perform deep contact research
Uncover insights like skills, work history, social links, and more
Discover, research and enrich contacts with Highperformr — Smarter, Faster
Explore contacts in-depth — from verified emails and phone numbers to LinkedIn activity, job changes, and more — all in one powerful view.
Highperformr AI helps you surface the right people and enrich your CRM with live, accurate contact insights so your teams can connect faster and close smarter.
- Track signals like job change, promotion, and LinkedIn activity
- Enrich contacts with verified email, phone, and social data instantly
- Automate enrichment and updates with powerful workflows
- Sync enriched contact info directly into your CRM and tools
Thousands of contacts — including decision-makers, influencers, and ICP matches — are just a search away.
Thousands of companies, including, are just a search away.